The G20 Global Pharma Summit Series-Canada is a prestigious platform that brings together leading experts in the pharmaceutical industry. A key topic of discussion at the summit is the role of Nanotechnology in Drug Delivery and Therapeutics.
Nanotechnology, the manipulation of matter at the atomic and molecular scale, has revolutionized drug delivery systems. It enhances the efficacy of drugs by improving bioavailability and allowing targeted delivery. This can significantly reduce side effects and improve patient compliance.
Therapeutics benefit from nanotechnology through the development of nanostructured materials and devices. These can be engineered to interact with cells and tissues at a molecular level, opening new avenues for disease diagnosis and treatment.
At the G20 summit, industry leaders, researchers, and policymakers discuss the latest advancements in nanotechnology, its potential in improving healthcare, and the challenges that need to be addressed to fully realize its benefits. The summit serves as a catalyst for fostering innovation and collaboration in this promising field.